Coagulation effect of sugammadex using thromboelastography in a randomized controlled study of surgical patients
Not Applicable
- Conditions
- Anticoagulant action of sugammadex
- Registration Number
- JPRN-UMIN000024163
- Lead Sponsor
- Korea University Guro Hospital Department of Anesthesiology and Pain Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Patients were excluded from study if they have neuromuscular disease, hereditary coagulation defect, renal or hepatic dysfunction, known allergy to sugammadex, recent history of hemorrhage or thrombosis within 30 days, difficult airway features, abnormal coagulation laboratory value (e.g., prothrombin time internalization normalized ratio >1.5, activated partial thromboplastin time > 50 sec), or if they were pregnant or women who were breast feeding.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method